Skip to main navigation
Skip to search
Skip to main content
UTMB Health Research Expert Profiles Home
Help & FAQ
Home
Experts
Departments
Equipment
Projects/Grants
Publications
Activities
Press/Media
Honors
Impacts
Search by expertise, name or affiliation
Anticomplementary Hepatitis B Antigen: Prognostic Importance in Chronic Active Liver Disease
Gary L. Gitnick
, William H.j. Summerskill
, Roger D. Soloway
, Susan Ritman
, Leslie J. Schoenfield
Research output
:
Contribution to journal
›
Article
›
peer-review
5
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Anticomplementary Hepatitis B Antigen: Prognostic Importance in Chronic Active Liver Disease'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Liver Disease
100%
Prednisone
100%
Prognostic Importance
100%
Hepatitis B Antigens
100%
Anti-complementary
100%
Placebo
40%
Antigen Test
20%
Poor Prognosis
20%
Treatment Failure
20%
Response to Treatment
20%
Treatment Trials
20%
Antibody Test
20%
Lupus Erythematosus
20%
Worse Prognosis
20%
Anti-smooth muscle Antibody
20%
Veterinary Science and Veterinary Medicine
Hepatitis B
100%
Prednisone
100%
Liver Disease
100%
Azathioprine
80%
Muscle
20%
Immunology and Microbiology
Hepatitis B Antigen
100%
Prednisone
100%
Azathioprine
80%
Smooth Muscle Antibody
20%
Lupus Vulgaris
20%